课题基金 / 基金详情

Scalable production, delivery and assessment of human pseudoislets for research and clinical applications

Scalable production, delivery and assessment of human pseudoislets for research and clinical applications
用于研究和临床应用的人类伪胰岛的可扩展生产、交付和评估
批准号:
395201
负责人:
Ungrin Mark D
金额:
$7.29万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-09-01 至 2019-09-01

项目摘要

项目成果

Ungrin Mark D的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Type 1 diabetes is caused by the loss of the insulin-producing beta cells. Located within "islets" in the pancreas, they detect levels of blood sugar, and release insulin as needed. Without them, patients must test their own blood sugar levels and then ca
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DNA event recording of the pericellular microenvironment, to understand the causes and mechanisms of beta-cell loss in pancreatic islet tissue
  • 批准号:
    472586
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2022
  • 负责人:
    Ungrin Mark D
  • 依托单位:
Optimizing the size and composition of beta cell aggregates to improve islet graft survival
  • 批准号:
    304249
  • 项目类别:
    Operating Grants
  • 资助金额:
    $42.73万
  • 财政年份:
    2014
  • 负责人:
    Ungrin Mark D
  • 依托单位:
海外基金